Prchal J F, Adamson J W, Murphy S, Steinmann L, Fialkow P J
J Clin Invest. 1978 Apr;61(4):1044-7. doi: 10.1172/JCI109003.
Bone marrow cells from two glucose-6-phosphate dehydrogenase (G-6-PD) heterozygotes with polycythemia vera were cultured to determine whether progenitors which wre not of the polycythemia vera clone were present, and, if present, which cell lines contributed to the increase in erythroid colonies observed in response to added erythropoietin (ESF). To accomplish this, the G-6-PD isoenzyme activity of individual erythroid colonies was determined. All of the erythroid colonies analyzed in cultures without added ESF, contained the G-6-PD isoenzyme type characteristic of the abnormal clone. With higher ESF concentrations in the culture, however, there was an increase in the colonies that were not of the polycythemia vera clone. Analysis of the ratio of the various types of colonies indicated that normal and polycythemia vera cells are capable of responding to ESF in vitro. In selected patients, this technique permits analysis of the ratios of normal to abnormal cells during the course of the disease, in response to therapy and during late complications, such as myelofibrosis or leukemic transformation.
对两名患有真性红细胞增多症的葡萄糖-6-磷酸脱氢酶(G-6-PD)杂合子的骨髓细胞进行培养,以确定是否存在非真性红细胞增多症克隆的祖细胞,以及如果存在的话,哪些细胞系导致了在添加促红细胞生成素(ESF)后观察到的红系集落增加。为实现这一点,测定了单个红系集落的G-6-PD同工酶活性。在未添加ESF的培养物中分析的所有红系集落,都含有异常克隆特有的G-6-PD同工酶类型。然而,在培养物中ESF浓度较高时,非真性红细胞增多症克隆的集落有所增加。对各种类型集落比例的分析表明,正常细胞和真性红细胞增多症细胞在体外都能够对ESF作出反应。在选定的患者中,这项技术可以在疾病过程中、对治疗的反应以及在诸如骨髓纤维化或白血病转化等晚期并发症期间,分析正常细胞与异常细胞的比例。